4//SEC Filing
Smith Julie 4
Accession 0001209191-22-035074
CIK 0001623526other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 5:00 PM ET
Size
5.4 KB
Accession
0001209191-22-035074
Insider Transaction Report
Form 4
Smith Julie
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2022-06-07+21,000→ 21,000 totalExercise: $12.96Exp: 2032-06-06→ Common Stock (21,000 underlying)
Footnotes (1)
- [F1]The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001557928
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 5:00 PM ET
- Size
- 5.4 KB